APR 4-5 BPAC

Results Wire: US FDA Blood Products Advisory Committee Discusses Recombinant Human Coagulation Factor IX GlycoPEGylated; Reviews Comments on the Donor Deferral Policy for MSM; and Hears About Research in the Laboratory of Emerging Pathogens Report